GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Sundry Debtors | ₹3,342 Cr | ₹1,858 Cr | ₹3,665 Cr | ₹3,101 Cr | ₹2,572 Cr |
What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2025 | ₹3,342 Cr |
Mar2024 | ₹1,858 Cr |
Mar2023 | ₹3,665 Cr |
Mar2022 | ₹3,101 Cr |
Mar2021 | ₹2,572 Cr |
How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2025 | ₹3,342 Cr | 79.83 | |
Mar2024 | ₹1,858 Cr | -49.30 | |
Mar2023 | ₹3,665 Cr | 18.19 | |
Mar2022 | ₹3,101 Cr | 20.57 | |
Mar2021 | ₹2,572 Cr | - |
Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹54,147.1 Cr | -1.4% | -10.5% | 12.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,388.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,513.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹126,733.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,292.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,935.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.4% |
-10.5% |
12.7% |
SENSEX | -1.8% |
-1.6% |
-2% |
You may also like the below Video Courses